A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations (SOLAR)

Clinical Trial ID NCT02588261

Rank	Title	Journal	Year	PubWeight™‹?›
1	Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC.	Front Oncol	2016	0.79